Substrate Binding Protein SBP2 of a Putative ABC Transporter as a Novel Vaccine Antigen of Moraxella catarrhalis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Infection and Immunity

• Publication date

  2014-06-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.01832-14PMID 24914218PMCID PMC4136220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Otitis Media with Effusion

  2019cited by this paper
• Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion

  2013influential reference
• COPD Surveillance—United States, 1999-2011

  2013cited by this paper
• Role of the Zinc Uptake ABC Transporter of Moraxella catarrhalis in Persistence in the Respiratory Tract

  2013cited by this paper
• Incidence Survey of Acute Otitis Media in Children in Sado Island, Japan—Sado Otitis Media Study (SADOMS)

  2013cited by this paper
• Acute Otitis Media Otopathogens During 2008 to 2010 in Rochester, New York

  2013cited by this paper
• Concurrent Assay for Four Bacterial Species Including Alloiococcus Otitidis in Middle Ear, Nasopharynx and Tonsils of Children with Otitis Media with Effusion: A Preliminary Report

  2012cited by this paper
• Branhamella catarrhalis as an Indirect Pathogen

  2012cited by this paper
• One third of middle ear effusions from children undergoing tympanostomy tube placement had multiple bacterial pathogens

  2012influential reference
• Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae.

  2011cited by this paper
• Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates

  2011cited by this paper
• Genome Analysis of Moraxella catarrhalis Strain RH4, a Human Respiratory Tract Pathogen

  2010influential reference
• Microbiology of Acute Otitis Media, Puget Sound Region, 2005-2009

  2010cited by this paper
• Characterization and Evaluation of the Moraxella catarrhalis Oligopeptide Permease A as a Mucosal Vaccine Antigen

  2010influential reference
• bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.

  2010cited by this paper
• Indirect Pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in Polymicrobial Otitis Media Occurs via Interspecies Quorum Signaling

  2010cited by this paper
• Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.

  2009cited by this paper
• Moraxella catarrhalis, a human respiratory tract pathogen.

  2009influential reference
• Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges

  2009cited by this paper
• New Vaccines Against Otitis Media: Projected Benefits and Cost-effectiveness

  2009cited by this paper
• Microbial Interactions during Upper Respiratory Tract Infections

  2008cited by this paper
• Mining the Moraxella catarrhalis Genome: Identification of Potential Vaccine Antigens Expressed during Human Infection

  2008cited by this paper
• Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

  2008cited by this paper
• CME ACTIVITY: Microbial Interactions during Upper Respiratory Tract Infections

  2008cited by this paper
• Moraxella catarrhalis Outer Membrane Protein CD Elicits Antibodies That Inhibit CD Binding to Human Mucin and Enhance Pulmonary Clearance of M. catarrhalis in a Mouse Model

  2007cited by this paper
• Global burden of COPD: risk factors, prevalence, and future trends.

  2007cited by this paper
• Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine

  2007cited by this paper
• Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles.

  2007cited by this paper
• The ABC Transporter Protein OppA Provides Protection against Experimental Yersinia pestis Infection

  2006cited by this paper
• Serologic Proteome Analysis of Borrelia burgdorferi Membrane-Associated Proteins

  2006cited by this paper
• Intranasal Vaccination with Recombinant Outer Membrane Protein CD and Adamantylamide Dipeptide as the Mucosal Adjuvant Enhances Pulmonary Clearance of Moraxella catarrhalis in an Experimental Murine Model

  2006cited by this paper
• Chronic obstructive pulmonary disease: current burden and future projections

  2006cited by this paper
• Human Antibody Response to Outer Membrane Protein G1a, a Lipoprotein of Moraxella catarrhalis

  2005cited by this paper
• Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.

  2005cited by this paper
• ATP-Binding Cassette Transporters Are Targets for the Development of Antibacterial Vaccines and Therapies

  2004cited by this paper
• Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously.

  2004influential reference
• Otitis media with effusion.

  2004cited by this paper
• Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance.

  2004cited by this paper
• Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli.

  2003cited by this paper
• Prediction of lipoprotein signal peptides in Gram‐negative bacteria

  2003influential reference
• Moraxella catarrhalis: from Emerging to Established Pathogen

  2002influential reference
• ABC transporters: one, two or four extracytoplasmic substrate‐binding sites?

  2002cited by this paper
• New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

  2002cited by this paper
• The microbiologic and immunologic basis for recurrent otitis media in children

  2001cited by this paper
• [Microbiology in acute otitis media].

  1998cited by this paper
• Interaction of Streptococcus pneumoniae andMoraxella catarrhalis: Investigation of the Indirect Pathogenic Role of β-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System

  1998cited by this paper
• Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions

  1997cited by this paper
• Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.

  1994cited by this paper
• Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media.

  1994cited by this paper
• Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells

  1993cited by this paper
• Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group.

  1990cited by this paper
• Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

  1989cited by this paper
• The concept of indirect pathogenicity by beta-lactamase production, especially in ear, nose and throat infection.

  1989cited by this paper
• Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen?

  1981cited by this paper

• Study of Antimicrobial Susceptibility Test For Moraxella Catarrhalis in Hospitalized Patients of Respiratory Tract Infection

  2026cites this paper
• Otitis media: recent advances in otitis media vaccine development and model systems

  2024cites this paper
• Screening of immunogenic proteins and evaluation of vaccine candidates against Mycoplasma synoviae

  2023cites this paper
• Prevalence of Moraxella Catarrhalis as a Nasal Flora among Healthy Kindergarten Children in Bhaktapur, Nepal

  2022cites this paper
• Moraxella catarrhalis: The virulence factor and pathogenesis strategy

  2021cites this paper
• Do we need a vaccine against Moraxella catarrhalis in chronic lung disease? What are the options and opportunities?

  2019cites this paper
• A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease

  2017influential citation
• Genomic structure and bacteriophages of Moraxella catarrhalis

  2017cites this paper
• Epidemiological and ecological modelling reveal diversity in upper respiratory tract microbial population structures from a cross-sectional community swabbing study

  2017cites this paper
• Potential impact of a Moraxella catarrhalis vaccine in COPD.

  2017cites this paper
• Selective substrate uptake: The role of ATP-binding cassette (ABC) importers in pathogenesis

  2017cites this paper
• Sulfate-Binding Protein (Sbp) from Xanthomonas citri: Structure and Functional Insights.

  2017cites this paper
• A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges

  2017cites this paper
• Antimicrobial activity of antisense peptide–peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms

  2017cites this paper
• Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development.

  2017cites this paper
• ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence

  2016cites this paper
• Sulfate-binding protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis.

  2016cites this paper
• Lipoproteins from Clostridium perfringens and their protective efficacy in mouse model.

  2015cites this paper
• Expeditious screening of candidate proteins for microbial vaccines.

  2015cites this paper
• The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis

  2015cites this paper
• Panel 6: Vaccines

  2013cites this paper